Telix Pharmaceuticals Limited (TLPPF) Financials

TLPPF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 1.2 billion 767.7 million
June 30, 2025 1.2 billion 768.0 million
Dec. 31, 2024 942.3 million 589.2 million
June 30, 2024 497.8 million 228.2 million

TLPPF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -63.1 million ?
June 30, 2025 11.1 million 11.6 million
Dec. 31, 2024 -6.8 million ?
June 30, 2024 13.3 million ?

TLPPF Net Income

No data available :(

TLPPF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 142.0 million 505.6 million 56.6 million
June 30, 2025 207.2 million 397.2 million 34.1 million
Dec. 31, 2024 441.4 million 347.9 million 6.6 million
June 30, 2024 79.3 million 12.3 million 6.9 million

TLPPF Shares Outstanding

No data available :(

TLPPF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 26.8 million 91.4 million 124.3 million -
June 30, 2025 6.7 million 81.5 million 96.6 million 48.9 million
Dec. 31, 2024 12.6 million 46.8 million 69.5 million 29.9 million
June 30, 2024 9.1 million 30.6 million 42.9 million -

TLPPF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 421.3 million 198.9 million
June 30, 2025 390.0 million 200.4 million
Dec. 31, 2024 369.2 million 129.5 million
June 30, 2024 126.1 million 43.4 million

TLPPF

Price: $10.48

52 week price:
5.91
16.76

Earnings Per Share: -0.02 USD

P/E Ratio: -350

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 4.2 billion

Links: